Receptor-mediated effects of endothelin on the L-type Ca++ current in ventricular cardiomyocytes

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 2, 1998, Pages 662-669

  Kelso, Elizabeth J ^a   Spiers, J Paul ^a   McDermott, Barbara J ^a   Scholfield, C Norman ^a   Silke, Bernard ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 BENZYL 4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 2 BUTENOIC ACID; ENDOTHELIN 1; ENDOTHELIN 1 [11-21]; ENDOTHELIN 3; ENDOTHELIN RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N ACETYL 10,11 DIHYDRO 5H DIBENZO[A,D]CYCLOHEPTEN 5 YLGLYCYLLEUCYLASPARTYLISOLEUCYLISOLEUCYLTRYPTOPHAN; RES 701 1;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HEART MUSCLE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; CALCIUM CHANNELS; ENDOTHELINS; HEART VENTRICLES; MALE; MEMBRANE POTENTIALS; MYOCARDIUM; RABBITS; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN;

EID: 0032443947     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Aramori I and Nakanishi S (1992) Coupling of two endothelin receptor subtypes to differing signal transduction in transfected Chinese hamster ovary cells. J Biol Chem 267:12468-12474.
2. Bax WA and Saxena PR (1994) The current endothelin receptor classification: Time for reconsideration? TIPS 15:379-386.
3. 2+ currents in cardiac cells. J Cardiovasc Pharmacol 26:S293-S296.
4. Cavero G, Miller WL, Heublein DM, Margulies KB and Burnett JC (1990) Endothelin in experimental congestive heart failure in the anaesthetised dog. Am J Physlol 259:F312-F317.
5. Cheng TH, Chang CY, Wei J and Lin CI (1995) Effects of endothelin-1 on calcium and sodium currents in isolated human cardiac myocytes. Can J Physiol Pharmacol 73:1774-1783.
6. A/B endothelin receptor-selective antagonists. J Cardiovasc Pharmacol 26:S358-S361.
7. Douglas SA, Meek TD and Ohlstein EH (1994) Novel receptor antagonists welcome a new era in endothelin biology. TIPS 15:313-316.
8. 2+ channels in cultured neonatal ventricular cardiomyocyte. Circ Res 71:1242-1253.
9. Fukuroda T, Ozaki S, Ihara M, Ishikawa K, Yano M and Nishikibe M (1994) Synergistic inhibition by BQ-123 and BQ-788 of endothelin-1-induced contractions of the rabbit pulmonary artery. Br J Pharmacol 113:336-338.
10. Habuchi Y, Tanaka H, Furukawa T, Tsujimura Y, Takahashi H and Yoshimura M (1992) Endothelin enhances delayed potassium current via phospholipase C in guinea-pig ventricular myocytes. Am J Physiol 262:H345-H354.
11. Haynes WG and Webb DJ (1993) The endothelin family of peptides: Local hormones with diverse roles in health and disease. Clin Sci 84:485-500.
12. Hori S, Komatsu Y, Shigemoto R, Mizuno N and Nakanishi S (1992) Distinct tissue distribution and cellular localisation of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors. Endocrinology 130:1884-1895.
13. Huggins JP, Pelton JT and Miller RC (1993) The structure and specificity of endothelin receptors: Their importance in physiology and medicine. Pharmac Ther 59:55-123.
14. Ishikawa T, Yanagisawa M, Kimura S, Goto K and Masaki T (1988a) Positive chronotropic effects of endothelin, a novel endothelium-derived vasoconstrictor peptide. Pflugers Arch 413:108-110.
15. Ishikawa T, Yanagisawa M, Kimura S, Goto K and Masaki T (1988b) Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea-pig atria. Am J Physiol 255:H970-H973.
16. B receptor antagonist, BQ-788. Proc Natl Acad Sci USA 91:4892-4896.
17. James FJ, Xie LH, Fujitani Y, Hayashi S and Horie M (1994) Inhibition of the cardiac protein kinase A-dependent chloride conductance by endothelin-1. Nature (Lond) 370:297-300.
18. Jones LG (1996) Inhibition of cyclic AMP accumulation by endothelin is pertussis-toxin-sensitive and calcium-independent in isolated adult feline cardiac myocytes. Life Sci 58:115-123.
19. Kelso EJ, McDermott BJ and Silke B (1995a) Actions of the novel vasodilator, flosequinan, in ventricular cardiomyocytes. J Cardiovasc Pharmacol 25:376-386.
20. Kelso EJ, McDermott BJ, Spiers JP, Silke B and Scholfield CN (1995b) Electrophysiological effects of BQ-123 on ventricular cardiomyocytes isolated from rabbit myocardium. J Mol Cell Cardiol 27:A129.
21. 2+ current from rabbit ventricular cardiomyocytes. Eur J Pharmacol 308:351-355.
22. Kohno M, Yasunari K, Murakawa K, Yokokawa K, Horio T and Fukui T (1990) Plasma immunoreactive endothelin in essential hypertension. Am J Med 88:614-618.
23. 125I]-endothelin-1 binding sites in rat brain. Neurosci Res 6:581-585.
24. 2+ current by a G protein-dependent mechanism in rabbit cardiac myocytes. J Physiol 448:729-747.
25. McMurray JJ, Ray SG, Abdullah I, Dargie HJ and Morton JJ (1992) Plasma endothelin in chronic heart failure. Circ 85:1374-1379.
26. Molenaar P, O'Reilly G, Sharky A, Kuc RE, Harding DP, Plumpton C, Gresham GA and Davenport AP (1993) Characterisation and localisation of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 72:526-538.
27. Moravec CS, Reynolds EE, Stewart RW and Bond M (1989) Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochem Biophys Res Commun 159:14-18.
28. Ono K, Tsujimoto G, Sakamoto A, Eto K, Masaki T, Ozaki Y and Satake M (1994) Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents. Nature 370:301-304.
29. Peter MG and Davenport AP (1996) Characterisation of the endothelin receptor selective agonist BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart. Br J Pharmacol 117:455-462.
30. Rubanyi GM and Polokoff MA (1994) Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46:325-415.
31. Sokolovsky M, Shraga-Levine Z and Galron R (1994) Ligand-specific stimulation/ inhibition of cyclic AMP formation by a novel endothelin receptor subtype. Biochem 33:11417-11419.
32. B receptors mediating venous smooth muscle contraction. Biochem Biophys Res Comm 200:627-633.
33. B receptor. Biochem Biophys Res Commun 184:953-959.
34. Takanashi M and Endoh M (1991) Characterization of the positive inotropic effect of endothelin on mammalian ventricular myocardium. Am J Physiol 261:H611-619.
35. Tanaka T, Tsukuda E, Nozawa M, Nonaka H, Ohno T, Kase H, Yamada K and Matsuda Y (1994) RES-701-1, a novel, potent, endothelin type B receptor-selective antagonist of microbial origin. Mol Pharmacol 45:724-730.
36. 2+ current in guinea-pig heart cells. Br J Pharmacol 99:437-438.
37. Tong L, Yali H and Wenping J (1995) The electrophysiological effects of endothelin: A patch clamp study in guinea-pig ventricular cardiomyocytes. Chinese Med J 108:618-625.
38. Varro A, Nanasi PP and Lathrop DA (1991) Voltage-clamp characteristics of ventricular myocytes in rabbit. Cardioscience 2:233-243.
39. A-receptors couple to inositol phosphate formation and inhibition of adenylate cyclase in human right atrium. J Cardiovasc Pharmacol 23:344-347.
40. Warner TD (1994) Endothelin receptor antagonists. Cardiovasc Drug Rev 12:105-122.
41. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K and Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (Lond) 332:411-415.